PRP vs. Stem Cell Therapy

A Spine-First Guide to Regenerative Medicine

Schedule Consultation Call Now

Key Facts: PRP vs. Stem Cell Therapy

  • Both PRP injections and stem cell therapy are autologous treatments, meaning they are sourced from your own body, which minimizes the risk of rejection or allergic reaction.
  • PRP delivers a concentrated dose of growth factors from your blood to stimulate healing. Stem cell therapy introduces mesenchymal cells from your bone marrow or fat tissue that can actively regenerate damaged structures.
  • Candidacy depends on your specific diagnosis, the severity of degeneration, and your individual healing potential.
  • VSI Regenerative Medicine offers both therapies, including a combined protocol using both simultaneously in some cases.
  • The right choice requires a physician-led evaluation, not a symptom checklist. Your age, overall health, imaging findings, and prior treatment history all factor into the decision.

What is the Difference Between PRP vs. Stem Cell Therapy

If you’ve been researching regenerative medicine for back pain, neck pain, or a joint injury, you’ve almost certainly encountered these two options: platelet rich plasma (PRP) therapy and stem cell therapy. They’re often mentioned in the same space, and they share a fundamental goal: helping your body heal. But they work differently, they’re suited to different situations, and they are not interchangeable.

The confusion is understandable. Much of what’s written about these therapies online is either too vague to be useful or pulls from a generic orthopedics context that doesn’t speak to spine patients at all. This guide is written from a spine-first perspective, drawing on the clinical approach of VSI and the peer-reviewed research that informs it.

What Is Regenerative Medicine? And Why Does It Matter for Spine and Joint Patients?

Regenerative medicine is the practice of using biological materials sourced from your own body to support, accelerate, or direct the healing of damaged tissue. Rather than blocking pain signals or removing tissue, regenerative therapies try to address what’s actually broken.

For spine and joint patients, this distinction matters enormously. Traditional pain management tools like corticosteroid injections can reduce inflammation temporarily, but they don’t rebuild a degenerating disc or repair a damaged tendon. Surgery can address structural problems, but it carries risk, recovery time, and in the case of spinal fusion, permanently alters the mechanics of your spine.

Regenerative therapies sit in a meaningful middle space: more targeted than pain management, less invasive than surgery, and designed to work with your body’s own biology.

PRP injections and stem cell therapy are the two most established regenerative injections in clinical use for spine and musculoskeletal conditions. Understanding how they differ is the first step toward knowing which one, if either, belongs in your treatment plan.

How PRP Therapy Works

PRP injections start with a sample of your own blood. That blood is processed in a centrifuge, which spins it at high speed to separate its components. Red blood cells are removed. What remains, and what gets injected, is plasma that is highly concentrated in platelets.

Platelets are best known for clotting, but their role in healing goes further. They carry a reservoir of growth factors that your body releases at the site of an injury to coordinate repair. In PRP, these growth factors include platelet-derived growth factor (PDGF), transforming growth factor-beta (TGF-β), vascular endothelial growth factor (VEGF), epidermal growth factor (EGF), and insulin-like growth factor (IGF-1).

Together, they signal cells to proliferate, reduce inflammation, promote new blood vessel formation, and begin rebuilding tissue matrices.

The logic behind PRP is that delivering a concentrated dose of these signals directly to a damaged structure (a degenerating disc, an inflamed facet joint, a torn tendon) amplifies a healing response that may have stalled or been insufficient on its own.

Every PRP injection at VSI is delivered under imaging guidance, and which type depends on what is being treated. For the spine, your physician uses X-ray guidance, also called fluoroscopy, which shows the bony landmarks that guide the needle to the right place to deliver the PRP effectively. For soft tissue and muscular targets, a rotator cuff for example, the choice is ultrasound, because it shows the nerves and the musculature directly. Depending on the site, you may be lying on the table or seated on a stool.

The injection itself takes roughly 10 to 20 minutes, depending on which structures are being targeted and how extensive the procedure is. Afterward you are brought to a recovery bay where your vitals are monitored and the team confirms you are feeling okay before you head home the same day.

How Stem Cell Therapy Works

The stem cells used in VSI’s protocols are mesenchymal stem cells (MSCs): adult stem cells drawn from your own body. They are autologous and orthobiologic in nature, meaning the biological material comes from you and is used to treat a musculoskeletal condition.


This is not embryonic stem cell therapy, systemic intravenous infusion, or “stem cell treatment” sold at international clinics with unproven, unregulated products.

VSI’s approach uses autologous MSCs harvested from your own bone marrow (via the hip/iliac crest) or from fat tissue. These are protocols grounded in peer-reviewed research and performed by physicians with specific training in regenerative injection techniques.

Mesenchymal stem cells are notable for two properties that make them valuable in this context. First, they are multipotent: they can differentiate into bone cells, cartilage cells, or fat cells depending on the environment they’re placed in. Second, they have anti-inflammatory and immunomodulatory properties. They don’t just build new tissue, they help regulate the biological environment that either supports or impedes healing.

In a damaged intervertebral disc, for example, MSCs injected into the nucleus pulposus can adopt characteristics of the disc’s native cells, potentially contributing to matrix regeneration and slowing further degeneration. At a joint like a knee or shoulder, they can support cartilage repair and modulate the chronic inflammatory cycle that drives osteoarthritis progression.

Bone marrow is typically extracted from the hip bone. The material is then centrifuged during the procedure to concentrate the mesenchymal cells. For adipose-derived protocols, fat is harvested from a small sample of the patient’s own tissue. X-Ray and ultrasound imaging guidance is used to ensure accurate delivery of injections, depending on the area being treated.

prp vs stem cell therapy for back pain,prp vs stem cell therapy,stem cell therapy vs prp for degenerative disc disease,bmac vs prp injection,is bmac the same as stem cell therapy,what is bmac injection,does stem cell therapy for back pain work,prp vs cortisone injection for back pain,injection alternative to spinal fusion,regenerative medicine spine specialist northern virginia

Other Medical Conditions Treated with PRP Therapy

Understanding the Difference Between PRP and Stem Cell Therapy

Are you wondering when to use Platelet Rich Plasma (PRP) or Stem Cell Therapy for spine and orthopedic conditions? In this video, Dr. Niteesh Bharara, Physiatrist and Face of Regenerative Medicine by Washingtonian Magazine, breaks it down using a simple analogy of growing a lawn or garden to help you understand how these regenerative therapies work.

PRP vs. Stem Cell Therapy: Comparison

The table below summarizes the core differences. The detail in each section below is what matters for your decision.

PRP TherapyStem Cell Therapy
Source materialYour blood (autologous)Your bone marrow or fat tissue (autologous)
Primary mechanismDelivers concentrated growth factors to stimulate existing cellsIntroduces new mesenchymal cells that can differentiate and modulate inflammation
Procedure complexityBlood draw, centrifuge, injection (lower complexity)Bone marrow aspiration or fat harvest, centrifuge, injection (higher complexity)
Downtime30 minutes30-60 minutes
Best suited forEarlier-stage degeneration, inflammation, soft tissue injuries, post-surgical supportModerate-to-advanced degeneration, structural tissue damage, conditions where new cell introduction is the goal
Can they be combined?Yes. PRP is frequently used alongside stem cell therapyYes. PRP creates a favorable environment for injected stem cells
Evidence statusGrowing body of clinical evidence for spine, joint, and tendon applicationsActive clinical development; Fast Track FDA designation received for intradiscal MSC therapy (2025)
Insurance coverageTypically out-of-pocketTypically out-of-pocket

When PRP Is Typically the Starting Point

PRP is usually the first regenerative therapy considered, for several reasons. The procedure is less involved and the recovery period is shorter. For patients with earlier-stage disc degeneration, facet joint irritation, mild osteoarthritis, or soft tissue injuries, PRP may provide sufficient biological stimulus to produce meaningful improvement.

PRP is also commonly used to support recovery after spine surgery, helping the healing environment at the operative site and potentially reducing post-surgical inflammation.

When Stem Cell Therapy May Be the Better Choice

Stem cell therapy is typically considered when the damage is more significant and what is needed is not just a stronger healing signal but the introduction of new cellular material. Moderate-to-advanced disc degeneration, cartilage loss, or conditions where the native cell population has been depleted or damaged are situations where stem cell therapy may offer more than PRP alone. Age and baseline healing capacity also factor into this.

When Both PRP and Stem Cells Are Used Together

VSI sometimes recommends a combined protocol: PRP and stem cell therapy administered in the same session or in close sequence.

The rationale is complementary: PRP creates a favorable growth factor environment that can support the survival, integration, and differentiation of the injected MSCs. This is not a universal recommendation and is made based on individual patient evaluation.

Conditions Treated with PRP and Stem Cell Therapy

These two therapies address a range of spine and musculoskeletal conditions. Not every condition is appropriate for every patient. Candidacy is determined through individual evaluation.

Spine Conditions

  • Degenerative disc disease (DDD): Intradiscal injections of PRP and/or MSCs target the nucleus pulposus to reduce inflammation, support matrix regeneration, and slow further degeneration. Research suggests both therapies can produce clinically significant improvements in pain and disability in discogenic back pain.
  • Disc herniation: PRP may be used to stimulate the healing environment around a herniated disc, complementing other non-surgical treatments such as spine-specialized physical therapy.
  • Facet joint syndrome / facet arthropathy: PRP injections into facet joints can reduce inflammation and pain associated with facet joint degeneration, offering a regenerative alternative to corticosteroid injections.
  • Sacroiliac joint pain: Both PRP and stem cell therapy can be applied to the sacroiliac joint for pain arising from degeneration or instability.
  • Cervical (neck) conditions: Regenerative injections are not limited to the lumbar spine. Cervical facet joints and disc-related neck pain can also be addressed through PRP.
  • Post-surgical support: PRP is used to support healing at the operative site following spine surgery, potentially enhancing recovery and reducing inflammation.

Sports Medicine and Joint Conditions

  • Osteoarthritis (knee, hip, shoulder): PRP injections reduce pain and inflammation in arthritic joints. Stem cell therapy may support cartilage repair in more advanced cases.
  • Tendon injuries: PRP has the strongest evidence base for tendinopathies, including rotator cuff tendinopathy, Achilles tendinopathy, patellar tendinopathy, and lateral epicondylitis (tennis elbow).
  • Ligament injuries: PRP and MSC therapy are used for partial ligament tears where surgical repair is not indicated or not preferred.
  • Muscle tears: For partial muscle tears in active patients, PRP can accelerate the healing response and reduce time to return to activity.
  • Labral tears (hip and shoulder): In appropriate cases, regenerative injections may be considered as a non-surgical option.
doctor consulting with patient back problems physical therapy concept

Who Is a Candidate for Regenerative Therapy?

One of the most important things we can tell you is that regenerative medicine is not a treatment for every diagnosis or every patient. At VSI, candidacy is determined by a physician who reviews your imaging, your history, and your overall health, not a checklist on a website.

Patients Who Tend to Be Good Candidates

  • Adults with degenerative spine conditions or joint pain who have not achieved adequate relief through conservative care (physical therapy, medications, standard injections)
  • Patients who want to explore non-surgical options before considering surgery
  • Patients seeking to delay or avoid spinal fusion by addressing the problem at a biological level
  • Athletes and active adults with tendon, ligament, or joint injuries that are slowing recovery or limiting performance
  • Patients in generally good health with preserved healing potential

Factors That May Affect Candidacy

  • Degree of degeneration: Regenerative therapies work best when there is still viable disc or tissue to heal. Advanced structural collapse, severe spinal stenosis with nerve compression, or complete tissue loss may not respond meaningfully, and surgery may be the more appropriate path.
  • Age and healing biology: Healing potential declines with age and is affected by conditions like diabetes, smoking history, and obesity, which can impair the body’s response to regenerative input.
  • Prior treatment history: Regenerative therapy is not typically a first-line treatment. Physicians generally look for evidence that conservative care has been tried and that the problem has not been resolved.
  • Nerve compression and instability: Regenerative therapy does not address structural instability or significant nerve compression. These conditions require evaluation for surgical options.

Find Out If You’re a Candidate

Most patients who come to VSI for a regenerative medicine consultation have already tried other approaches, and many have been told that surgery is their only remaining option. Often, that’s not true.

VSI has helped more than 100,000 patients find real answers over more than three decades and 90% of our patients are healed without the need for surgery. As an independent practice, VSI refuses to let insurance dictate care decisions. The goal is always finding the right solution for you, not the easiest.

VSI also offers complementary regenerative and injection options beyond PRP and stem cell therapy, including fat injections using microfragmented adipose tissue, VIA Disc NP (a non-surgical injection designed to cushion degenerative discs), and prolotherapy for ligament and joint support. The right combination depends on your specific anatomy and goals.

Schedule Consultation Call Now

Meet the Specialists Who Perform PRP and Stem Cell Therapy

Our team includes board-certified spine specialists with extensive experience performing PRP for low back pain and orthopedic conditions. Each physician takes a personalized approach, combining advanced imaging and a comprehensive approach that focuses on your goals for treatment and recovery.

Dr. Niteesh Bharara
physician bharara
Dr. Niteesh Bharara

Dr. Niteesh Bharara is a double-board certified physiatrist who is recognized in the top 7% of physicians in the United States. Leading the Mid-Atlantic region in regenerative therapies and injections such as stem cell therapy, PRP therapy, VIA Disc and adipose fat injections, he’s earned the title of Face of Regenerative Medicine by Washingtonian Magazine and Top Doctor recognition in consecutive years.

Learn More
previous arrow
next arrow

Frequently Asked Questions on Platelet Rich Plasma Therapy

There is no universal answer to this question. It depends on your specific diagnosis, the degree of degeneration or tissue damage, your age and health, and what you’ve already tried. A physician evaluation with imaging review is the only way to determine which therapy, if either, is appropriate for your situation. VSI offers consultations specifically to answer this question.

PRP uses growth factors from your own blood to stimulate healing. Stem cell therapy uses mesenchymal cells from your bone marrow or fat tissue to introduce new cells that can regenerate damaged tissue and modulate inflammation. PRP amplifies your body’s existing repair response. Stem cell therapy supplements it with new biological material.

Yes. VSI sometimes recommends a combined protocol in the same session. PRP creates a growth factor-rich environment that can support the survival and function of injected stem cells. Whether a combined approach is appropriate depends on your individual evaluation.

Regenerative therapies are not immediate pain relief. The biological processes they initiate take time, and improvements are typically gradual and may continue over weeks to months following treatment. Typically, patients will feel results from regenerative treatments after a few weeks.

No. There is a significant difference between the autologous, physician-administered protocols VSI offers and unregulated stem cell products promoted by some clinics online or abroad. VSI’s protocols use cells sourced from your own body through established clinical procedures. Products using allogeneic (donor) cell lines, amniotic tissue, or exosome preparations marketed as stem cell therapies are a different category entirely, and the FDA has taken enforcement action against several such products. Be cautious of any provider offering stem cell therapy derived from outside your own body for orthopedic conditions.

Some employer-sponsored self-insured plans have begun covering regenerative therapies, although many patients pay out-of-pocket. VSI does not allow insurance coverage decisions to influence clinical recommendations.

For some patients, yes. Regenerative therapy may provide sufficient relief and functional improvement that surgery is delayed, reduced in scope, or avoided altogether. This is one reason VSI takes a full-spectrum approach, evaluating regenerative options before recommending surgery. But the right answer depends entirely on your diagnosis. In cases involving significant nerve compression, structural instability, or advanced degeneration, surgery may be the appropriate path, and regenerative therapy would not substitute for it.

BMAC stands for Bone Marrow Aspirate Concentrate. It refers to the concentrated preparation of bone marrow that is produced when marrow is aspirated from the iliac crest (hip bone) and processed through a centrifuge. BMAC contains mesenchymal stem cells, growth factors, and other regenerative components. In spine and orthopedic medicine, BMAC and stem cell therapy are often used interchangeably to describe this autologous, bone-marrow-derived regenerative injection.

Yes. Regenerative injections are not limited to the lumbar spine. Cervical facet joints and disc-related neck pain are also treated through VSI’s regenerative medicine protocols, using the same imaging-guided approach.

Cortisone (corticosteroid) injections reduce inflammation quickly and are widely covered by insurance. But they do not regenerate tissue. Their benefit is typically temporary, and repeated use can degrade tissue integrity over time. Regenerative therapies take longer to work but aim to address the biological source of pain rather than suppressing the inflammatory signal that pain is producing.